ARF6 Antibodies

Santa Cruz Biotechnology delivers a wide array of ARF6 monoclonal antibodies for research focused on understanding ADP-ribosylation factor 6 (ARF6) in cellular processes. ARF6 monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). ARF6 is a small GTPase that plays a critical role in regulating membrane trafficking, cytoskeletal dynamics, and cell signaling. Its involvement in processes such as endocytosis and exocytosis makes ARF6 essential for maintaining cellular homeostasis and responding to extracellular signals. Dysregulation of ARF6 has been implicated in various diseases, including cancer and neurodegenerative disorders, highlighting its importance as a target for therapeutic intervention. ARF6 monoclonal antibodies enable researchers to explore membrane trafficking pathways and their impact on cellular function. Understanding ARF6's role in disease progression can lead to new therapeutic strategies. ARF6 monoclonal antibodies from Santa Cruz Biotechnology support cutting-edge research that advances our understanding of cellular regulation and disease mechanisms.